 The trial showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival. Read Full Story The post Dow Jones Newswires: GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint appeared first on ForexTV... 